PD-1 expression and clinical PD-1 blockade in B-cell lymphomas von Xu-Monette, Zijun Y., Zhou, Jianfeng, Young, Ken H.

Volltext

Checkpoint inhibitors in hematological malignancies von Ok, Chi Young, Young, Ken H

Volltext

New agents and regimens for diffuse large B cell lymphoma von Wang, Liang, Li, Lin-rong, Young, Ken H.

Volltext

PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response? von Xu-Monette, Zijun Y, Zhang, Mingzhi, Li, Jianyong, Young, Ken H

Volltext

RNA-mediated immunotherapy regulating tumor immune microenvironment: next wave of cancer therapeutics von Pandey, Poonam R, Young, Ken H, Kumar, Dhiraj, Jain, Neeraj

Volltext

EBV-positive diffuse large B-cell lymphoma of the elderly von Ok, Chi Young, Papathomas, Thomas G., Medeiros, L. Jeffrey, Young, Ken H.

Volltext

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management von Ok, Chi Young, Li, Ling, Young, Ken H

Volltext

MYD88 L265P Mutation in Lymphoid Malignancies von Yu, Xinfang, Li, Wei, Deng, Qipan, Li, Ling, Hsi, Eric D, Young, Ken H, Zhang, Mingzhi, Li, Yong

Volltext

Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vinc... von MARIE GREEN, Tina, YOUNG, Ken H, MØLLER PEDERSEN, Lars, BOE MØLLER, Michael, VISCO, Carlo, XU-MONETTE, Zijun Y, ORAZI, Attilio, GO, Ronald S, NIELSEN, Ole, GADEBERG, Ole V, MOURITS-ANDERSEN, Torben, FREDERIKSEN, Mikael

Volltext

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma von Zhang, Jun, Medeiros, L Jeffrey, Young, Ken H

Volltext

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma von Li, Xin, Cheng, Yasong, Zhang, Mingzhi, Yan, Jiaqin, Li, Ling, Fu, Xiaorui, Zhang, Xudong, Chang, Yu, Sun, Zhenchang, Yu, Hui, Zhang, Lei, Wang, Xinhua, Wu, Jingjing, Li, Zhaoming, Nan, Feifei, Tian, Li, Li, Wencai, Young, Ken H

Volltext

B-cell receptor–mediated NFATc1 activation induces IL-10/STAT3/PD-L1 signaling in diffuse large B-cell lymphoma von Li, Li, Zhang, Jun, Chen, Juan, Xu-Monette, Zijun Y., Miao, Yi, Xiao, Min, Young, Ken H., Wang, Sa, Medeiros, L. Jeffrey, Wang, Michael, Ford, Richard J., Pham, Lan V.

Volltext

Clinical and pathological characteristics of HIV- and HHV-8–negative Castleman disease von Yu, Li, Tu, Meifeng, Cortes, Jorge, Xu-Monette, Zijun Y., Miranda, Roberto N., Zhang, Jun, Orlowski, Robert Z., Neelapu, Sattva, Boddu, Prajwal C., Akosile, Mary A., Uldrick, Thomas S., Yarchoan, Robert, Medeiros, L.Jeffrey, Li, Yong, Fajgenbaum, David C., Young, Ken H.

Volltext

HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy von Wan, Xin, Young, Ken H, Bai, Ou

Volltext

PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination von Yu, Xinfang, Li, Wei, Liu, Haidan, Wang, Xu, Coarfa, Cristian, Cheng, Chao, Yu, Xinlian, Zeng, Zhaoyang, Cao, Ya, Young, Ken H, Li, Yong

Volltext

miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy von Huang, Qian, Xia, Jiajia, Wang, Lei, Wang, Xu, Ma, Xiaodong, Deng, Qipan, Lu, Yong, Kumar, Munish, Zhou, Zhiyuan, Li, Ling, Zeng, Zhaoyang, Young, Ken H, Yi, Qing, Zhang, Mingzhi, Li, Yong

Volltext

Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract von Soderquist, Craig R., Patel, Nupam, Murty, Vundavalli V., Betman, Shane, Aggarwal, Nidhi, Young, Ken H., Xerri, Luc, Leeman-Neill, Rebecca, Lewis, Suzanne K., Green, Peter H., Hsiao, Susan, Mansukhani, Mahesh M., Hsi, Eric D., de Leval, Laurence, Alobeid, Bachir, Bhagat, Govind

Volltext

SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in... von Bao, Changqian, Tao, Xiandong, Cui, Wei, Yi, Bin, Pan, Tiewen, Young, Ken H., Qian, Wenbin

Volltext

Ibrutinib in combination with rituximab in relapsed or refractory mantle cell lymphoma: a single-centre, open-label, phase 2 trial von Wang, Michael L, Prof, Lee, Hun, MD, Chuang, Hubert, MD, Wagner-Bartak, Nicolaus, MD, Hagemeister, Frederick, Prof, Westin, Jason, MD, Fayad, Luis, MD, Samaniego, Felipe, MD, Turturro, Francesco, Prof, Oki, Yasuhiro, MD, Chen, Wendy, PA, Badillo, Maria, MSN, Nomie, Krystle, PhD, Rosa, Maria DeLa, BS, Zhao, Donglu, MD, Lam, Laura, PhD, Addison, Alicia, MS, Zhang, Hui, BSN, Young, Ken H, MD, Li, Shaoying, MD, Santos, David, MD, Medeiros, L Jeffrey, Prof, Champlin, Richard, Prof, Romaguera, Jorge, Prof, Zhang, Leo, MD

Volltext

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma von Pang, Yuyang, Lu, Tingxun, Xu-Monette, Zijun Y, Young, Ken H

Volltext